Glaxo Avandia FDA Adversity Prompts Doubts of Revenue, Share Resurgence

(Bloomberg) -- GlaxoSmithKline Plc convinced a U.S.
regulatory panel this week to keep its best-selling diabetes
drug, Avandia, on the market. Now comes the hard part: persuading
doctors to use a medicine linked to heart attacks.

The U.S. Food and Drug Administration committee of advisers
said this week that the diabetes pill should carry new warnings
about cardiovascular risks. Glaxo shares had their biggest gain
in two years yesterday after the advisory panel decided not to
recommend the withdrawal of Avandia, which brought in $3.3
billion in 2006 for the London-based company, Europe's largest
drugmaker.


Read more at Bloomberg Exclusive News

FTSE 100 Rallies Most in 14 Months, Paced by GlaxoSmithKline, Lloyds TSB

(Bloomberg) -- U.K. stocks rose for the first time
in six days as profit reports from Lloyds TSB Group Plc and
SABMiller Plc reassured investors that earnings growth will be
sustained. The FTSE 100 Index rallied the most in 14 months.

GlaxoSmithKline Plc advanced after a panel of U.S. doctors
voted to keep the company's diabetes pill Avandia on the market.
Alliance & Leicester Plc rallied on takeover speculation.


Read more at Bloomberg Stocks News

European Bank Stocks Advance, Led By ABN Amro; Saipem, Technip Decline

(Bloomberg) -- European bank stocks rose, led by ABN
Amro Holding NV after Royal Bank of Scotland Group Plc sweetened
its 71.1 billion-euro ($98.1 billion) offer for the Dutch lender.

ABN Amro jumped the most in three months. Oil-services
companies paced declines in energy shares after UBS AG cut its
recommendations on Saipem SpA and Technip SA following their
``strong performance.'' BT Group Plc, the U.K.'s largest phone
company, and drugmaker GlaxoSmithKline Plc climbed after
brokerages lifted their recommendations on the shares.


Read more at Bloomberg Stocks News

European Bank Stocks Advance, Paed by ABN Amro; Saipem, Technip Decline

(Bloomberg) -- European bank stocks rose, led by ABN
Amro Holding NV after Royal Bank of Scotland Group Plc sweetened
its 71.1 billion-euro ($98.1 billion) offer for the Dutch lender.

ABN Amro jumped the most in three months. Oil-services
companies paced declines in energy shares after UBS AG cut its
recommendations on Saipem SpA and Technip SA following their
``strong performance.'' BT Group Plc, the U.K.'s largest phone
company, and drugmaker GlaxoSmithKline Plc advanced after
brokerages lifted their recommendations on the shares.


Read more at Bloomberg Stocks News

European Stocks Advance, Led by ABN Amro, Barclays, BT Group, Glaxo

(Bloomberg) -- European stocks rose for a third day,
led by ABN Amro Holding NV after Royal Bank of Scotland Group Plc
sweetened its 71.1 billion-euro ($98.1 billion) offer for the
Dutch lender, seeking to trump Barclays Plc.

ABN Amro jumped the most in three months. Barclays also
climbed. BT Group Plc, the U.K.'s largest phone company, and
drugmaker GlaxoSmithKline Plc rose after brokerages lifted their
recommendations on the shares.


Read more at Bloomberg Stocks News

UK warns consumers on contaminated fake toothpaste

(Reuters) - LONDON, July 12 - British authorities issued an alert on Thursday after contaminated counterfeit versions of GlaxoSmithKline Plc's Sensodyne toothpaste were found.



The discovery follows a series of similar fake toothpaste scares around the world.


Read more at Reuters.com Government Filings News